Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kiromic Biopharma Inc
(NQ:
KRBP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Kiromic Biopharma Inc
< Previous
1
2
3
Next >
KRBP DEADLINE ALERT: ROSEN, A TOP RANKED FIRM, Encourages Kiromic BioPharma, Inc. Investors With Losses to Secure Counsel Before Important October 4 Deadline in Securities Class Action - KRBP
October 02, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
KIROMIC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kiromic BioPharma, Inc. and Encourages Investors to Contact the Firm
September 30, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Kiromic BioPharma, Inc. (NASDAQ:KRBP) Investor Notice: Deadline in Lawsuit on October 4, 2022
September 29, 2022
San Diego, CA -- (SBWIRE) -- 09/29/2022 -- A deadline is coming up on October 4, 2022 in the lawsuit filed for certain investors of Kiromic BioPharma, Inc. (NASDAQ:KRBP).
Via
SBWire
ROSEN, A TOP RANKED LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important October 4 Deadline in Securities Class Action - KRBP
September 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
NATIONALLY RANKED ROSEN LAW FIRM Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important October 4 Deadline in Securities Class Action - KRBP
September 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
Kiromic BioPharma, Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds KRBP Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf
September 21, 2022
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
TOP RANKED ROSEN LAW FIRM Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP
September 15, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
ROSEN, LEADING INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP
September 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP
September 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP
August 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
Kiromic Biopharma, Inc. Shareholder News: Robbins LLP is Investigating Kiromic Biopharma, Inc. (KRBP) on Behalf of Shareholders
August 22, 2022
From
Robbins LLP
Via
Business Wire
NASDAQ:KRBP Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Kiromic BioPharma, Inc.
August 19, 2022
San Diego, CA -- (SBWIRE) -- 08/19/2022 -- An investor, who purchased NASDAQ:KRBP shares, filed a lawsuit against Kiromic BioPharma, Inc over alleged violations of Federal Securities Laws by Kiromic...
Via
SBWire
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc. (KRBP) and Encourages Investors with Significant Losses to Contact the Firm
August 19, 2022
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Kiromic BioPharma, Inc. (KRBP) Investors of Class Action and to Actively Participate
August 18, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP
August 17, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP
August 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
Kiromic Biopharma, Inc. Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Kiromic Biopharma, Inc. (KRBP)
August 12, 2022
From
Robbins LLP
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Kiromic BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – KRBP
August 10, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Kiromic Biopharma, Inc. (KRBP)
August 09, 2022
From
Robbins LLP
Via
Business Wire
KIROMIC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Kiromic BioPharma, Inc. and Encourages Investors to Contact the Firm
August 09, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm
August 09, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm
August 08, 2022
From
The Schall Law Firm
Via
Business Wire
Kiromic BioPharma Appoints Leonardo Mirandola, Ph.D. as Chief Scientific Officer
July 12, 2022
From
Kiromic BioPharma, Inc.
Via
Business Wire
Kiromic BioPharma Achieves Milestone with Timely Completion of Expanded cGMP Manufacturing Facility to Support Cell Therapy Oncology Pipeline
July 07, 2022
From
Kiromic BioPharma, Inc.
Via
Business Wire
Kiromic BioPharma Pipeline to Prioritize a New Gamma Delta T-cell Product Candidate
June 21, 2022
From
Kiromic BioPharma, Inc.
Via
Business Wire
Kiromic BioPharma Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement
June 07, 2022
From
Kiromic BioPharma, Inc.
Via
Business Wire
NASDAQ:KRBP Shareholder Alert: Investigation over Possible Wrongdoing at Kiromic BioPharma, Inc.
May 26, 2022
San Diego, CA -- (SBWIRE) -- 05/26/2022 -- Certain directors of Kiromic BioPharma, Inc. are under investigation over potential breaches of fiduciary duties by certain directors.
Via
SBWire
Kiromic BioPharma Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
May 13, 2022
From
Kiromic BioPharma, Inc.
Via
Business Wire
Kiromic BioPharma Announces Company Will Directly Submit Amended IND for Procel™ to the FDA in Second Half of 2022
May 11, 2022
From
Kiromic BioPharma, Inc.
Via
Business Wire
Kiromic BioPharma Announces Availability of Company’s Current Corporate Presentation
April 11, 2022
From
Kiromic BioPharma, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.